Twenty five year follow-up for breast cancer incidence and mortality

No Nephrology here but,  its all over the news so...

http://www.bmj.com/content/348/bmj.g366

Interesting responses/critic and at times dismissal of the trial results:
http://www.bmj.com/content/348/bmj.g366?tab=responses

Risk of End-Stage Renal Disease Following Live Kidney Donation

http://jama.jamanetwork.com/article.aspx?articleid=1829682

Median follow-up of 7.6 years (maximum, 15.0)

Estimated risk of ESRD at 15 years after donation was 30.8 per 10 000 (95% CI, 24.3-38.5) in kidney donors and 3.9 per 10 000 (95% CI, 0.8-8.9) in their matched healthy nondonor counterparts (P < .001). 

Estimated risk of 74.7 per 10 000 black donors (95% CI, 47.8-105.8) vs 23.9 per 10 000 black nondonors (95% CI, 1.6-62.4; P < .001) 

Estimated risk of 22.7 per 10 000 white donors (95% CI, 15.6-30.1) vs 0.0 white nondonors (P < .001).

 Estimated lifetime risk of ESRD was 90 per 10 000 donors, 326 per 10 000 unscreened nondonors (general population), and 14 per 10 000 healthy nondonors.

Conclusions: Compared with matched healthy nondonors, kidney donors had an increased risk of ESRD over a median of 7.6 years; however, the magnitude of the absolute risk increase was small.